Breast Carcinoma — Trials

Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 873
Recruiting: 478
Ph III recruiting: 55
Growth YoY: −2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 401–450 of 962 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04419181	Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer	withdrawn	Phase 2	0	University of RochesterOTHER	1	Oct 14, 2025	clinicaltrials
NCT04009044	Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast	active not recruiting	Phase 2	156	Northwestern UniversityOTHER	1	Oct 9, 2025	clinicaltrials